Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published August 19, 2025

Lannett 10mg ADHD Medication Recall: Foreign Tablet Found

Lannett recalls 10mg ADHD medication bottles with foreign tablets. Consumers should check for 5mg tablets in 100-count bottles. No immediate action needed but verify product details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0642-2025DrugLannett ›
Take action

Contact the company

Recalling firmLannett Company Inc.1101 C Ave W · Seymour, IN 47274-3342
✎ GovInfoNow plain-language explainer

Lannett is recalling 10mg ADHD medication tablets that contain an extra 5mg tablet. This foreign tablet could cause incorrect dosing if taken, potentially leading to unsafe medication levels. Read more at govinfonow.com/recall/31865-lannett-10mg-adhd-medication-recall-foreign-tablet-found.

Source Summary by GovInfoNow · govinfonow.com/recall/31865-lannett-10mg-adhd-medication-recall-foreign-tablet-found · Updated August 18, 2026 · FDA enforcement record: FDA #D-0642-2025

Cite this page

“Lannett 10mg ADHD Medication Recall: Foreign Tablet Found.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/31865-lannett-10mg-adhd-medication-recall-foreign-tablet-found. Based on FDA recall #D-0642-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0642-2025%22&limit=1).

The FDA announced on August 19, 2025, that Lannett Company Inc. is recalling Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, due to the presence of foreign tablets. Owners should contact the company for a remedy.

How to tell if you have it

  • Brand: Lannett
  • Product: Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct
  • NDC: 0527-0762-37
  • Lot#: 25283185A
  • Expiry: 02/28/2027
  • Quantity: 4,848 bottles
  • Distribution: OH

The hazard

Two bottles contained one tablet of the 5 mg strength instead of the labeled 10 mg. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Lannett Company Inc. has 13 other recalls on record since October 11, 2018. Other recent recalls of similar products include Dextroamphetamine Extended-Release Capsules (June 26, 2026), Lannett Niacin Extended-release Tablets (May 27, 2026), and Lannett Primidone Tablets (April 24, 2026). Other recent recalls of similar products include Golden State Baclofen Tablets (November 26, 2025), Granules Pharmaceuticals Trazodone 50mg (January 26, 2026), and Amgen Corlanor 5mg Tablets (June 4, 2026).

How to tell if you have this one

Check for bottles labeled as 10mg ADHD medication with 100 tablets. Look for the lot number 25283185A and expiration date 02/28/2027 on the packaging.

  • Brand
    Lannett
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number 25283185A and expiration date 02/28/2027 on the packaging.

Where it went and when

Where it was distributed

Distributed in Ohio.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “OH” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Ohio.

Recall timeline

FDA published this recall 29 days after the firm started it.

1. Firm started the recall: Aug 19, 202512. FDA classified it Class II: Sep 11, 202523. Published in FDA’s Enforcement Report: Sep 17, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Lannett Primidone Tablets Recall: Cross Contamination Risk
LannettLannett Niacin Extended-release Tablets Recall: Failed Dissolution Testing
LannettGolden State Baclofen Tablets Recall: Foreign Tablets Risk
Golden State Medical SupplyGranules Pharmaceuticals Trazodone 50mg Recall: Foreign Tablets Found
Granules PharmaceuticalsAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health Packaging

Other Lannett recalls

Lannett Company Inc. recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
June 26, 2026

Latest drug recalls

Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,
Teva Pharmaceuticals · September 29, 2026Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,
Preferred Pharmaceuticals · September 28, 2026SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0642-2025 (August 19, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0642-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA